World Stroke Organization #MondayTips
Every Monday, WSA Social Media Leader Rodrigo Guerrero publishes a #MondayTip on the WSA WorldStrokeEd Twitter account, covering a specific stroke related topic. You can find a compilation of our #MondayTips here!
#MondayTip
New AHA dyslipidemia guides emphasizes earlier &➕ intensive LDL-C⬇️, often requiring non-statin therapy
PCSK9 options:
🧬Inclisiran (siRNA):↓PCSK9 production, dosing every 6m
💉Alirocumab/Evolocumab:✋circulating PCSK9
Both ↓LDL~50–60%, including in stroke patients
Missed what happened in February at @WorldStrokeEd? 👀
Catch up with our monthly newsletter!
🎓 Upcoming & past webinars
🎙️ New podcast episodes
📊 Fresh infographics
💡 Latest #MondayTips by @interneurona
🤓 Read it here:
https://www.world-stroke-academy.org/news/february-newsletter-3/
#StrokeEducation #StrokeCare
#MondayTip
#Stroke is not the same in #women and men
☝️Women have unique risk factors (pregnancy complications, menopause), are more likely to be misdiagnosed, rec&eive thrombolysis less often, despite similar benefit
Time for sex-responsive stroke care
https://doi.org/10.1177/17474930251393009
#MondayTip
Hypoperfusion Intensity Ratio
#HIR may be the most practical collateral biomarker in AIS
⬆️High HIR (>0.4) → rapid core growth, ↑ hemorrhage risk, worse mRS.
⬇️Low HIR → robust collaterals & better EVT outcomes.
https://doi.org/10.3174/ajnr.A8557
#MondayTip
Cancer-related stroke ≠ routine ESUS
~50% of strokes in active cancer are cryptogenic, but many are cancer-driven hypercoagulable events
🔁14–29% recur at 1 year
⚖️Anticoag vs aspirin? Still equipoise
🧠Classify. Risk-stratify. Individualize
https://doi.org/10.1161/str.0000000000000517
#MondayTip
Cancer-related stroke ≠ routine ESUS
~50% of strokes in active cancer are cryptogenic, but many are cancer-driven hypercoagulable events
🔁14–29% recur at 1 year
⚖️Anticoag vs aspirin? Still equipoise
🧠Classify. Risk-stratify. Individualize
https://doi.org/10.1161/str.0000000000000517
#MondayTIP
#FLAIR hyperintense vessels ≠ clot
🧩Hemodynamic clue!
🧠Distal FVH→collateral flow
⏱ Early window→possible viable penumbra
⚠️In TIA→ think persistent large-vessel stenosis
☝️Sometimes FLAIR tells you what perfusion can’t
🔎Look closely
https://bit.ly/4rntsAA
#MondayTip
#ISC2026
🌎ISC delivered fewer “home runs” and more hard truths: what works, what doesn’t, and where selection matters most in stroke care
From extended-window thrombolysis to FXIa inhibition, #ISC26 highlights where stroke care is truly moving — and where it isn’t.
🌍 Activate Quality in Stroke Care: From Measurement to Impact
🔗 Register now for our global webinar: https://us06web.zoom.us/webinar/register/WN_Rzg6SEJrT06jl188ouyD6Q#/
@strokecareresq @ESOstroke
#RESQ #Stroke #MissionThrombectomy #StrokeCare #QualityOfCare #HealthcareQuality #StrokeRegistry
#PaperOfTheMonth
⚧️Sex and gender shape stroke risk, presentation, treatment, and outcomes
✍️This new scientific statement explains why we must move beyond describing #disparities to delivering #equitable stroke care
📄 Read more: https://www.world-stroke-academy.org/news/the-paper-of-the-month-march-5
#MondayTip
New AHA dyslipidemia guides emphasizes earlier &➕ intensive LDL-C⬇️, often requiring non-statin therapy
PCSK9 options:
🧬Inclisiran (siRNA):↓PCSK9 production, dosing every 6m
💉Alirocumab/Evolocumab:✋circulating PCSK9
Both ↓LDL~50–60%, including in stroke patients
Missed what happened in February at @WorldStrokeEd? 👀
Catch up with our monthly newsletter!
🎓 Upcoming & past webinars
🎙️ New podcast episodes
📊 Fresh infographics
💡 Latest #MondayTips by @interneurona
🤓 Read it here:
https://www.world-stroke-academy.org/news/february-newsletter-3/
#StrokeEducation #StrokeCare